| Revenue | — | — |
| EBITDA | DKK -4K | +12% |
| Net profit | DKK 24K | -8% |
| Total assets | DKK 2,3M | +3% |
| Equity | DKK 496K | +5% |
| Employees | — | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -5 | -4 | — | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -185 | -4 | -4 | -3 | -4 | -5 | -4 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -185 | -4 | -4 | -3 | -4 | -5 | -4 |
| Net financials | -759 | 88 | 52 | 245 | 66 | 39 | 30 | 28 |
| Profit before tax | -763 | -97 | -114 | 241 | 62 | 35 | 25 | 24 |
| Tax | 2 | 2 | 2 | 7 | -0 | -0 | -0 | -0 |
| Net profit | -765 | -99 | -115 | 234 | 62 | 35 | 26 | 24 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1.614 | 1.692 | 1.736 | 2.016 | 2.121 | 2.203 | 2.277 | 2.350 |
| Equity | 330 | 230 | 115 | 349 | 411 | 446 | 472 | 496 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.284 | 1.461 | 1.621 | 1.667 | 1.710 | 1.756 | 1.805 | 1.854 |
| Total debt | 1.284 | 1.461 | 1.621 | 1.667 | 1.710 | 1.756 | 1.805 | 1.854 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KE Management | Management | 2009 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KREN HOLDING ApS | Company | 100.0% | 100.0% | 2014 |
VERLAND CAPITAL ApS | Company | 25.0% | 25.0% | 2009 |
PHARMAVIE A/S | Company | 25.0% | 25.0% | 2009 |
| Individual | 20.0% | 20.0% | 2009 |
| Person | Role here | Other companies |
|---|---|---|
| Kren Erik Whittard Nielsen | Management | 0 companies |